Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The primary objective is to directly estimate brain glutathione concentrations in vivo using
H-MRS at 7T before and after initiation of Tecfidera in established multiple sclerosis (MS)
patients considering switching therapy or being treatment-naive (first line).